Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe COVID-19 Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04794400
What this trial is testing

The Application of a Mask in Patients With Severe Covid-19 Already Treated With High-flow Nasal Cannula.

Who this might be right for
Covid19
Region Skane 18
Not applicableStudy completedNCT04577235
What this trial is testing

Correlation Between Thoracic Ultrasound and Thorax Computed Tomography Scores.

Who this might be right for
COVID-19
Gaziosmanpasa Research and Education Hospital 29
Large-scale testing (Phase 3)Ended earlyNCT04329611
What this trial is testing

ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease

Who this might be right for
COVID-19
Dr. Michael Hill 148
Testing effectiveness (Phase 2)Study completedNCT04707664
What this trial is testing

Sargramostim Use in COVID-19 to Recover Patient Health

Who this might be right for
Covid19SARS-CoV Infection
Partner Therapeutics, Inc. 600
Not applicableStudy completedNCT04926428
What this trial is testing

In Situ Thrombolysis With tPA and Inflow Perfusion Analysis in Patient With Severe Covid-19 Infection

Who this might be right for
COVID-19
Grupo Mexicano para el Estudio de la Medicina Intensiva 15
Not applicableStudy completedNCT04760990
What this trial is testing

Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort.

Who this might be right for
Multiple SclerosisCOVID-19 (Severe Coronavirus Disease 2019)
University Hospital, Basel, Switzerland 1,181
Post-approval studies (Phase 4)Study completedNCT05049213
What this trial is testing

Effect of Local Treatment(Carrageenan Nasal Spray and PVP-I Mouthwash) in Reducing Viral Load in Patients With COVID-19

Who this might be right for
Covid19SARS-CoV 2 Infection
National Taiwan University Hospital 7
Large-scale testing (Phase 3)Ended earlyNCT04713176
What this trial is testing

Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients

Who this might be right for
Severe COVID-19
Daewoong Pharmaceutical Co. LTD. 240
Not applicableUnknownNCT04345315
What this trial is testing

Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent.

Who this might be right for
COVID-19SARS-CoV-2
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 500
Testing effectiveness (Phase 2)Ended earlyNCT04458948
What this trial is testing

Non-comparative Trial of the Combination of HCQ and AZI in the Treatment of ICU Patients

Who this might be right for
COVID-19
University of New Mexico 28
Not applicableStudy completedNCT04609462
What this trial is testing

High-Flow Nasal Cannula in Severe COVID-19 With Acute Hypoxemic Respiratory Failure.

Who this might be right for
Covid19Acute Hypoxemic Respiratory Failure
Fundacion Clinica Valle del Lili 199
Testing effectiveness (Phase 2)Ended earlyNCT04377659
What this trial is testing

Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection

Who this might be right for
COVID-19
Memorial Sloan Kettering Cancer Center 9
Early research (Phase 1)UnknownNCT05083000
What this trial is testing

Reducing Hypoxia in Patients With Coronavirus Disease (COVID-19) Using Topotecan With Standard of Care

Who this might be right for
COVID-19 Respiratory Infection
National University Hospital, Singapore 24
Testing effectiveness (Phase 2)UnknownNCT04622865
What this trial is testing

Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19

Who this might be right for
SARS-CoV 2COVID-19Coronavirus Disease 2019
AB Science 200
Early research (Phase 1)Study completedNCT04646044
What this trial is testing

A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19

Who this might be right for
Covid-19Coronavirus Disease 2019
Nektar Therapeutics 30
Large-scale testing (Phase 3)Ended earlyNCT04516811
What this trial is testing

Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19

Who this might be right for
COVID-19SARS-CoV-2 InfectionSevere Acute Respiratory Syndrome Coronavirus 2
South African National Blood Service 102
Large-scale testing (Phase 3)Ended earlyNCT04928430
What this trial is testing

Efficacy and Safety of XAV-19 for the Treatment of Moderate-to-severe COVID-19

Who this might be right for
COVID-19
Xenothera SAS 290
Testing effectiveness (Phase 2)Study completedNCT04530136
What this trial is testing

Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19

Who this might be right for
Confirmed Coronavirus Disease
Pharming Technologies B.V. 38
Large-scale testing (Phase 3)Ended earlyNCT04952519
What this trial is testing

Efficacy of Amantadine Treatment in COVID-19 Patients

Who this might be right for
Patients With Moderate or Severe COVID-19
Noblewell 193
Large-scale testing (Phase 3)Study completedNCT04380519
What this trial is testing

Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19)

Who this might be right for
COVID-19
R-Pharm International, LLC 372
Next Page